J&J last week launched a research center hosted at the London School of Hygiene & Tropical Medicine (LSHTM) that will focus on antimicrobial resistance (AMR) and next-generation TB drug regimens. The J&J Satellite Center for Global Health Discovery at LSHTM marks the first in a planned series of academic research centers, according to a company press release.

Each center will partner with academic institutions to focus on threats with high unmet need, including AMR,…


British researchers have developed a rapid diagnostic blood test that can detect and distinguish between the six strains of T. cruzi, the parasite that causes Chagas disease, Imperial College London announced last week.

Co-developed with the London School of Hygiene and Tropical Medicine and Kent-based nonprofit TroZonX17 (among others), the technology may lead to “widespread, inexpensive testing,” according to a TroZonX17 press release.

Britain’s government announced on Sunday $160 million in new funding and a faster construction timeline for its Vaccines Manufacturing and Innovation Centre (VMIC), which will now come online a year early, in summer 2021. The nonprofit facility—founded by Oxford University, Imperial College London and the London School of Hygiene & Tropical Medicine—will also see a twentyfold expansion in planned production capacity, to 70 million vaccine doses within six months of opening.